Chlorhexidine Gluconate CHG Cloth Market

Surgical site infections or SSI are common surgical complications. Chlorhexidine gluconate (CHG) cloths are premoistened with an FDA-approved antiseptic solution to help reduce bacteria on the skin before surgery. The rinse-free formula stays on the skin and is trusted by nurses to help reduce the risk of developing an SSI. Rising surgical site infections and a strong recommendation for the use of CHG products as an antiseptic agent by authorized healthcare organizations have led to the growth of the global chlorhexidine gluconate (CHG) cloth market in the recent years. However, side-effects of CHG are likely to restrain the market growth over the forecast period.

The global chlorhexidine gluconate (CHG) cloth market is growing at a rapid pace and is projected to reach USD 16,469.14 thousand by 2023 from USD 13,167.00 thousand in 2017 at a CAGR of 3.80% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 48.70% share, followed by Europe and Asia-Pacific with shares of 28.41% and 16.57%, respectively.

The market has been segmented based on product, CHG concentration, application, and distribution channel.

The global chlorhexidine gluconate (CHG) cloth market has been segmented, based on product, CHG impregnated cloth, and CHG compatible/non-impregnated cloth. Based on product, the CHG impregnated cloth segment accounted for the largest market share of 64.28% in 2017, with a market value of USD 8,463.21 thousand, and is projected to register a CAGR of 4.32% during the forecast period. The CHG compatible/non-impregnated cloth segment accounted for a market share of 35.72% in 2017, with a market value of USD 4,703.79 thousand, which is projected to register a CAGR of 2.82% during the forecast period.

The global chlorhexidine gluconate (CHG) cloth market, based on CHG concentration, has been segmented into 2% chlorhexidine gluconate cloth and 4% chlorhexidine gluconate cloth. Based on CHG concentration, the 2% chlorhexidine gluconate cloth segment accounted for the larger market share of 75.77% in 2017, with a market value of USD 9,976.47 thousand, which is projected to register a CAGR of 4.22% during the forecast period. The 4% chlorhexidine gluconate cloth segment is projected to register a 24.23% CAGR during the forecast period and accounted for USD 3,190.53 thousand in 2017.

The global chlorhexidine gluconate (CHG) cloth market, based on application, has been segmented into surgical preparation and personal care. Based on application, the surgical preparation segment accounted for the larger market share of 76.15% in 2017, with a market value of USD 10,027.16 thousand, which is projected to register a CAGR of 4.22% during the forecast period. The personal care segment is projected to register a 23.85% CAGR during the forecast period and accounted for USD 3,139.84 thousand in 2017.

The global chlorhexidine gluconate (CHG) cloth market, based on distribution channel, has been segmented into hospital and retail pharmacies and online platforms. Based on distribution channel, the hospital and retail pharmacies segment accounted for the larger market share of 57.02% in 2017, with a market value of USD 7,507.56 thousand, which is projected to register a CAGR of 3.90% during the forecast period. The online platforms segment is projected to register a 42.98% CAGR during the forecast period and accounted for USD 5,659.44 thousand in 2017.